Hypomagnesemia in Critically Ill Patients on Kidney Replacement Therapy
Hypomagnesemia is a common electrolyte disorder in critically ill patients and is associated with increased morbidity and mortality risk. Many clinical conditions may contribute to hypomagnesemia through different pathogenetic mechanisms. In patients with acute kidney injury (AKI) the need for continuous or prolonged intermittent kidney replacement therapy (CKRT and PIKRT, respectively) may further add to other causes of hypomagnesemia, especially when regional citrate anticoagulation (RCA) is used. This webinar explores strategies aimed at how precisely tailoring both dialysis prescriptions and the composition of KRT fluids, as well as early magnesium supplementation and close monitoring of magnesium, including ionized magnesium could represent a cornerstone in reducing KRT-related hypomagnesemia.
Presenters:
Francesca Di Mario, MD
Internal Medicine and Nephrology
Parma University Medical School, Parma, Italy